🕒 Last update: loading…19/11/2026

Stock ChromaDex Corporation CDXC

ChromaDex Corporation — Investlytic score 2/5 on the five criteria.

-
-
40/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 2/5 criteria met. Data as of 01/11/2026.

  • ✅ Price trend passed
  • ❌ Growth failed
  • ✅ Debt passed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): the price has been multiplied by at least 1.5.

Price change 2018 → 2019: 25.66%

Price change 2019 → 2020: 11.37%

Price change 2020 → 2021: -22.08%

Price change 2021 → 2022: -55.08%

Price change 2022 → 2023: -14.88%

Price change 2023 → 2024: 271.33%

Price change 2024 → 2025: 15.63%

Price change 2025 → 2026: 0.00%

Financial growth

Revenue CAGR (8 years): -100.00%

Earnings CAGR (8 years): N/A

Growth status: insufficient data or negative trend.

Debt

Debt-to-equity ratio: 0.04

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 71.55

P/E > 25.0 (maximum threshold).

Correction (6 months)

Price history over 6 months not available.

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, mechanical verdict of the method (hold, watch, sell: the same for all) and the detail of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…
03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by ChromaDex Corporation over the latest fiscal years.

Revenue
129 m USD
fiscal year 2025
Net income
17.4 m USD
fiscal year 2025
Net margin
13.4 %
fiscal year 2025
Average annual growth
+16.9 %
Revenue growth over 5 years
Average annual growth
+21.9 %
Revenue growth over 10 years
Market cap
164 m USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
202059.3 m-19.9 m-33.6 %n/a
202167.4 m-27.1 m-40.2 %+13.8 %
202272.0 m-16.5 m-23.0 %+6.8 %
202383.6 m-4.9 m-5.9 %+16.0 %
202499.6 m8.6 m8.6 %+19.2 %
2025129 m17.4 m13.4 %+29.9 %

Amounts converted to USD. Source: published annual accounts, collected on 19/11/2026.

+

Valuation and competitors

ChromaDex Corporation compared with its sector on the same exchange and with its main competitors.

Company P/E
12.9
38.0 % below the sector
Sector median P/E
20.8
healthcare, Nasdaq
Sector over 10 years
28.2
10-year median, range 20.4 to 45.8

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 13/11/2026. Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering ChromaDex Corporation publish: ratings, price targets and earnings forecasts.

Majority rating
buy
6 analysts

Breakdown of ratings

strong buy 0buy 6hold 0sell 0strong sell 0

Price targets: published for companies listed in the United States only.

Track record against expectations: reported EPS above consensus 11 times over the last 12 releases.

Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee. Company data collected from its NAGE listing (same ISIN).

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
Nasdaq
IPO: 25/06/2008
ISIN code
US1710774076
Workforce
104
full-time employees
Chief executive
Frank Louis Jaksch Jr.

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about ChromaDex Corporation

What is the revenue of ChromaDex Corporation?

129 m USD for fiscal year 2025, with net income of 17.4 m USD (net margin 13.4 %).

What do analysts say about ChromaDex Corporation?

Out of 6 analysts: 6 buy or strong buy, 0 hold, 0 sell or strong sell.

What is the P/E ratio of ChromaDex Corporation?

Trailing 12-month P/E of 12.9, against 20.8 for the sector median on the same exchange (10-year median: 28.2).

Is ChromaDex Corporation stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US1710774076).

How many employees does ChromaDex Corporation have?

104 full-time employees according to the latest published profile.

Who runs ChromaDex Corporation?

Frank Louis Jaksch Jr. is the company's chief executive.